SETD2 and dysplasia: Lack of SETD2 expression in intestinal tissues is associated with decreased number of mucus-producing goblet cells, immune cells infiltrate, high levels of pro-inflammatory cytokines and chemokines, loss of the mucosal barrier integrity and epithelium inflammatory injury that can progress toward high-grade dysplasia.